期刊文献+

RP-HPLC法测定血浆中奥卡西平及其代谢产物的浓度 被引量:7

Simultaneous Determination of Oxcarbazepine and Its Metabolite in Human Plasma by RP-HPLC
下载PDF
导出
摘要 目的:建立反相高效液相色谱法同时测定血浆中奥卡西平(OXC)及其活性代谢产物-10-单羟基代谢物(MHD)的浓度。方法:采用Waters X-TerraTM RP_(18)柱(150mm×3.9mm,5μm),柱温35℃,流速1.2ml·ml^(-1),流动相:甲醇-O.1%三氟乙酸(30:70),检测波长232nm。甲喹酮作为内标,血浆样品经蛋白沉淀法处理后直接进样测定。结果:OXC在0.625~37.50μg·ml^1,MHD在1.25~75.0μg·ml^(-1)的范围线性关系良好。OXC低、中、高三种浓度的提取回收率分别为109.9%,102.0%,104.1%。日内RSD为1.69%~3.61%,日间RSD为2.73%~7.45%;MHD低、中、高三种浓度的提取回收率分别为108.0%,107.3%,102.6%,日内RSD4.41%~5.75%,日间RSD 1.32%~7.06%。结论:该方法准确,简单,快速,可用于OXC临床治疗的药物浓度监测和药物动力学的研究。 Objective : To establish a HPLC method for the simultaneous determination of oxcarbazepine (OXC) and active metabolite( 10-monohydroxy metabolite, MHD) in human plasma. Method: The Waters X-TerraTM RP18( 150mm ×3.9mm, 5μm)was used , flow-rate was 1.2ml. min^-1 at 35 ℃, mobile phase consisted of methanol -0.1% trifuroacetic acid (30: 70), detection wavelength was 232 nm. Methaqualon was used as internal standard. The samples were extracted by protein precipitation. Result: The method was found to be linear over the concentration ranges ( OXC 0. 625 - 37.50μg.ml^-1 and MHD 1.25 - 75.0μg.ml^-1 ). The extraction recovery of low, middle and high concentration OXC was 109.9%, 102.0% and 104. 1% respectively, the intra-RSD was 1.69% - 3.61%, and inter-RSD was 2.73% -7.45%. The extraction recovery of low, middle and high concentration MHD was 108.0%, 107.3% and 102.6% respectively, the intra-RSD was 4.41% -5.75%, and inter-RSD was 1.32% - 7.06%. Conclusion: The method is acurate, simple and rapid. It is suitable for the therapeutic drug monitoring and pharmacokinetic research.
出处 《中国药师》 CAS 2009年第12期1689-1691,共3页 China Pharmacist
基金 深圳市科技计划项目(200702144)
关键词 奥卡西平 单羟基代谢物 反相高效液相色谱法 药物浓度监测 Oxcarbazepine (OXC) Monohydroxy metabolite (MHD) RP-HPLC Therapeutic drug monitoring
  • 相关文献

参考文献5

二级参考文献36

  • 1焦正,钟明康,施孝金,李中东,张静华,王宏图.抗癫癎药物监测[J].中国临床药学杂志,2004,13(6):386-389. 被引量:17
  • 2Jiyatshku G. Manufacture of urea derivative [P]. JP: 56073066,1981-06-17. (CA 1981, 95: 187104). 被引量:1
  • 3Milanese A. Process for the preparation of 10-oxo- 10,1 1-dihydro-SH-dibenz [b,f] azepin-5-carboxamide [P]. US:5808058, 1998-09-15. (CA 1996, 125: 195448). 被引量:1
  • 4Hinder W. 10-Oxo-10, 11-dihydro-dibenzazepine derivative [P]. DE: 2011087, 1970-09-24. (CA 1970, 73: 109711). 被引量:1
  • 5Knell A, Monti D, Balker A. Catalytic dehydrogenation of iminodibenzyl to iminostilbene. A comparison of potassium-promoted manganese, iron and cobalt oxide catalyst [J]. Catal Lett, 1995, 31 (2,3) : 197-207. (CA 1995, 122: 290699). 被引量:1
  • 6Knell A, Monti D, Maciejewski M, et al. Catalytic dehydrogenation of 10,11-dihydro-SH-dibenz[b,f]azepine(iminodibenzyl) to 5H-dibenz [b,f] azepine (iminostilbene)over potassium-promoted iron oxides [J]. Appl Catal A, 1995,121 (1) : 139-58. (CA 1995, 122: 109299). 被引量:1
  • 7Eckardt R,Jaensch HJ. Process for the manufacture of 5H-dibenz [b,f] -azepine-5-carboxamide from iminostilbene and alkali cyanates [P]. DE: 4307181, 1994-11-10. (CA 1995, 122:105697). 被引量:1
  • 8Kawashima K, Ishiguro T. Dibenzoxirenazepine derivatives[P]. DE: 2246842, 1973-04-05. (CA 1973, 79: 5322). 被引量:1
  • 9Heckendorn R, Zergenyi J. Process for the rearrangement of 10,11-epoxy- 10,11-dihydro-SH-dibenz [b,f] azepines to give 10-oxo- 10,11-dihydro-SH-dibenz [b,f] azepines [P]. CH:633271, 1982-11-30. (CA 1980, 92: 128762). 被引量:1
  • 10Palitzsch E Mueller R, Richter E. Preparation of 5-carbamoyl-SH-dibenz [b,f] azepine [P]. DD:297962, 1992-01-30.(CA 1992, 116: 214378). 被引量:1

共引文献31

同被引文献116

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部